Dr. Nick Housby

Dr. Nick Housby is a co-founder and CEO of Accunea Ltd, a medical device company with real-time diagnostic monitoring products for organ transplantation.

Nick has a PhD in Microbial Genetics from the University of Warwick followed by postgraduate research (genomics/biotechnology) at Harvard and Oxford University. Nick has held senior level positions as Scientist, CEO, NED, investor, and Chairman in several startup enterprises – such as the Oxford University startup, Oxagen (Human Genetics, 2003), Novolytics (antimicrobial therapeutics, 2010), BioMimox (peptide aptamers, 2014), and Arcamis (business consulting, 2010) – and has served as the Director of Business Development at OBN (2012). Nick has raised significant public, private, VC, and business angel funding (Beer and Partners, 2013) for several businesses) and was a coach for the Growth Accelerator program. More recently, Nick created the Molecular Diagnostics Centre within the John Radcliffe Hospital, Oxford, building self-sustainability models and international collaborations and partnerships. Nick also led the successful bid to become the Oxford Genomics Medicine Centre and the Director of the Program. Nick is currently a member of the Diagnostics Advisory Council in Oxfordshire; has advised on Genomics products for ThermoFisher; was a lecturer at MIB (Manchester) in genomics; and graduated in 2016 with a PGDiP in Strategy and Innovation from the Said Business School in Oxford.